Vijay Chopra

23.6k total citations
39 papers, 527 citations indexed

About

Vijay Chopra is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Vijay Chopra has authored 39 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Vijay Chopra's work include Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (10 papers) and Cardiac pacing and defibrillation studies (9 papers). Vijay Chopra is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (10 papers) and Cardiac pacing and defibrillation studies (9 papers). Vijay Chopra collaborates with scholars based in India, United States and United Kingdom. Vijay Chopra's co-authors include Stefan D. Anker, Inder S. Anand, Carolyn S.P. Lam, Tiew‐Hwa Katherine Teng, Wan Ting Tay, Mark Richards, Jasper Tromp, Adriaan A. Voors, Gurpreet Singh Wander and Wouter Ouwerkerk and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Vijay Chopra

38 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijay Chopra India 11 338 113 110 57 51 39 527
Rosa Coppolecchia United States 3 382 1.1× 79 0.7× 183 1.7× 39 0.7× 31 0.6× 5 525
Miklós Rohla Austria 15 419 1.2× 33 0.3× 125 1.1× 38 0.7× 25 0.5× 54 605
Yasir Parviz United Kingdom 12 240 0.7× 55 0.5× 177 1.6× 105 1.8× 38 0.7× 28 442
Jonathan Seltzer United States 13 346 1.0× 54 0.5× 117 1.1× 35 0.6× 56 1.1× 30 546
Samuel Adamsson Eryd Sweden 10 325 1.0× 136 1.2× 55 0.5× 105 1.8× 18 0.4× 18 537
Francesco Perone Italy 15 314 0.9× 50 0.4× 129 1.2× 95 1.7× 26 0.5× 56 558
Chloe A. Allen Maycock United States 8 317 0.9× 99 0.9× 208 1.9× 48 0.8× 57 1.1× 11 527
Rahman Shah United States 13 426 1.3× 44 0.4× 281 2.6× 109 1.9× 66 1.3× 50 680
Haiyan Xu China 16 573 1.7× 120 1.1× 132 1.2× 28 0.5× 28 0.5× 61 743
Amit Zachariah United States 2 473 1.4× 53 0.5× 39 0.4× 71 1.2× 14 0.3× 2 535

Countries citing papers authored by Vijay Chopra

Since Specialization
Citations

This map shows the geographic impact of Vijay Chopra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijay Chopra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijay Chopra more than expected).

Fields of papers citing papers by Vijay Chopra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijay Chopra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijay Chopra. The network helps show where Vijay Chopra may publish in the future.

Co-authorship network of co-authors of Vijay Chopra

This figure shows the co-authorship network connecting the top 25 collaborators of Vijay Chopra. A scholar is included among the top collaborators of Vijay Chopra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijay Chopra. Vijay Chopra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Udell, Jacob A., Patricia Campbell, Javed Butler, et al.. (2025). Prevention of heart failure after acute myocardial infarction. The Lancet. 406(10508). 1154–1170. 3 indexed citations
2.
Jadhav, Uday, et al.. (2023). Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade. Cureus. 15(9). e45241–e45241. 5 indexed citations
3.
Khan, Muhammad Shahzeb, Stefan D. Anker, Gerasimos Filippatos, et al.. (2023). Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial. Journal of Cardiac Failure. 29(10). 1345–1354. 1 indexed citations
4.
Siddiqi, Tariq Jamal, Stefan D. Anker, Gerasimos Filippatos, et al.. (2023). Health Status Across Major Subgroups of Patients with Heart Failure and Preserved Ejection Fraction. European Journal of Heart Failure. 25(9). 1623–1631. 10 indexed citations
5.
Teramoto, K., Wan Ting Tay, Jasper Tromp, et al.. (2022). Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry. Circulation Cardiovascular Quality and Outcomes. 16(1). e009134–e009134. 1 indexed citations
6.
7.
Docherty, Kieran F., Inder S. Anand, Chern‐En Chiang, et al.. (2022). Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF. JACC Asia. 2(2). 139–153. 7 indexed citations
8.
Mohan, Jagdish C., Jamshed Dalal, Vijay Chopra, et al.. (2022). Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus. Indian Heart Journal. 74(6). 441–449. 3 indexed citations
9.
Ray, Saumitra, et al.. (2021). Cost-Consequence Analysis of Sacubitril/Valsartan versus Enalapril in Chronic Heart Failure Patients with Reduced Ejection Fraction. SHILAP Revista de lepidopterología. 1 indexed citations
10.
11.
Tan, Eugene S.J., Vera J. Goh, Bernadet T. Santema, et al.. (2020). Ethnic Differences in Atrial Fibrillation Among Patients with Heart Failure in Asia. ESC Heart Failure. 7(4). 1419–1429. 7 indexed citations
12.
Cunningham, Jonathan W., Muthiah Vaduganathan, Brian Claggett, et al.. (2020). Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 8(5). 372–381. 65 indexed citations
13.
Beusekamp, Joost C., Tiew‐Hwa Katherine Teng, Wan Ting Tay, et al.. (2019). Potassium Abnormalities in Patients with Heart Failure from 11 Asian Regions: Insights from the ASIAN-HF Registry. European Journal of Heart Failure. 22(4). 751–754. 4 indexed citations
14.
Han, Yaling, Ji-yan Chen, Vijay Chopra, et al.. (2019). ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand. Journal of clinical lipidology. 14(1). 98–108.e8. 35 indexed citations
15.
Chopra, Vijay, Sanjay Mittal, Manish Bansal, Balbir Singh, & Naresh Trehan. (2019). Clinical profile and one-year survival of patients with heart failure with reduced ejection fraction: The largest report from India. Indian Heart Journal. 71(3). 242–248. 20 indexed citations
16.
Teng, Tiew‐Hwa Katherine, Jasper Tromp, Wan Ting Tay, et al.. (2018). Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. The Lancet Global Health. 6(9). e1008–e1018. 118 indexed citations
17.
Mohan, Viswanathan, et al.. (2015). Treatment of Type 2 Diabetes with a Breakable Extended Release Gliclazide Formulation in Primary Care: The Xrise Study.. PubMed. 63(12). 26–29. 7 indexed citations
18.
Dani, Sameer, et al.. (2014). Prevalence of sympathetic overactivity in hypertensive patients – A pan India, non-interventional, cross sectional study. Indian Heart Journal. 66(6). 686–690. 10 indexed citations
19.
Mega, Jessica L., Eugene Braunwald, Sabina A. Murphy, et al.. (2013). RIVAROXABAN IN THE SETTING OF CONTINUED DUAL ANTIPLATELET THERAPY: FINDINGS FROM THE ATLAS ACS 2-TIMI 51 TRIAL. Journal of the American College of Cardiology. 61(10). E4–E4. 2 indexed citations
20.
Tang, W.H. Wilson, Vijay Chopra, Niranjan Chakravarthy, Imad Libbus, & Rodolphe P. Katra. (2010). External Wireless Monitoring of Bioimpedance in Heart Failure Patients: Results from the ACUTE Study. Journal of Cardiac Failure. 16(8). S70–S71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Coppolecchia Breakdown of academic impact, for papers by Miklós Rohla Breakdown of academic impact, for papers by Yasir Parviz Breakdown of academic impact, for papers by Jonathan Seltzer Breakdown of academic impact, for papers by Samuel Adamsson Eryd Breakdown of academic impact, for papers by Francesco Perone Breakdown of academic impact, for papers by Chloe A. Allen Maycock Breakdown of academic impact, for papers by Rahman Shah Breakdown of academic impact, for papers by Haiyan Xu Breakdown of academic impact, for papers by Amit Zachariah
Rankless by CCL
2026